The 10 - year Warfarin and Aspirin for Reduced Cardiac Ejection Fraction (WARCEF) trial is the largest randomized, double -
blind comparison of aspirin and warfarin (also known by its brand name Coumadin) for heart failure, following 2,305 heart failure patients whose heart muscle pumps less oxygen - rich blood into the body, known as reduced ejection fraction, at 168
study sites in 11 countries on three continents.
This report reviews 16
studies conducted in seven states; 103 of 112
comparisons show positive results in writing achievement favoring students in classrooms of NWP participants, based on grading by «
blind» coders who did not know whether the author received NWP teaching.